weight management Tag

01 Oct

Posted at 12:29h in Weight Research

Prescription Medication Notice: Tirzepatide is a prescription medication that should only be prescribed and monitored by your healthcare provider. Do not start, stop, or change your dose without medical guidance. Approved uses vary by country. Tirzepatide is not suitable for everyone, including people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2), and it should not be used during pregnancy. Tell your healthcare provider if you have a history of pancreatitis, gallbladder disease, kidney problems, or diabetic eye disease, or if you take insulin, sulfonylureas, or oral contraceptives. Common side effects include nausea, vomiting, diarrhea, and constipation. Seek prompt medical care for severe or persistent abdominal pain, signs of dehydration, or symptoms of an allergic reaction.

Managing metabolic health over forty feels a lot like optimising a complex product strategy. When your body’s baseline insulin sensitivity shifts, relying solely on willpower to restrict calories can trigger intense hunger signals that undermine your long-term goals.

Modern medical weight management has evolved beyond simple caloric restriction toward treatments that act on how your brain and gut communicate.

If you are exploring dual-action hormone treatments like mounjaro in Singapore, understanding how tirzepatide targets both GIP and GLP-1 receptors helps explain how it can reduce food noise and support weight loss. A properly supervised medical program, combined with adequate protein and strength training, can help support steady fat loss while limiting muscle loss.

[caption id="attachment_76409" align="aligncenter" width="500"]Sustainable Weight Loss meds pexels Photo by Pixabay[/caption]

15 Jan

Posted at 22:20h in Author Interviews, JAMA, Surgical Research, Weight Research
MedicalResearch.com Interview with: [caption id="attachment_39315" align="alignleft" width="150"]Jøran Hjelmesæth MD, PhD Professor, Head Morbid Obesity Centre and Section of Endocrinology Department of Medicine Vestfold Hospital Trust Tønsberg, Norway Department of Endocrinology, Morbid Obesity and Preventive Medicine Institute of Clinical Medicine University of Oslo, Norway Prof. Hjelmesæth[/caption] Jøran Hjelmesæth MD, PhD Professor, Head Morbid Obesity Centre and Section of Endocrinology Department of Medicine Vestfold Hospital Trust Tønsberg, Norway Department of Endocrinology, Morbid Obesity and Preventive Medicine Institute of Clinical Medicine University of Oslo, Norway MedicalResearch.com: What is the background for this study? What is known?  Some previous studies have shown beneficial long-term effects of bariatric surgery on the remission and incidence of diabetes, hypertension and dyslipidemia, whilst high quality data on the long-term incidence of adverse effects, mental health conditions and complications after bariatric surgery are sparse or lacking. In addition, the control groups in previous studies of the effect of bariatric surgery seldom or never received any specific specialist based non-surgical treatment alternative. The present pragmatic real world study was performed at a publicly funded single tertiary care obesity center in Norway where patients could choose between bariatric surgery and specialized medical treatment (voluntarily and free of charge). Nearly complete short- and long-term (≤ 10 years) data on beneficial and detrimental outcomes were retrieved from national registries (Norwegian Prescription Database and Norwegian Patient Registry).  The results confirm the beneficial long-term effects of bariatric surgery (gastric bypass) on the remission and incidence of diabetes, hypertension and dyslipidemia, as demonstrated in some previous studies.

16 Dec

Posted at 16:45h in Author Interviews, Cost of Health Care, Johns Hopkins, Weight Research
MedicalResearch.com Interview with: Ruchi Doshi, MPH MD Candidate 2017 | Johns Hopkins University School of Medicine MedicalResearch.com: What is the background for this study? What are the main findings? Response: Current guidelines recommend that physicians collaborate with non-physician health professionals to deliver weight management care. While several studies have looked at barriers physicians face in providing these services, few studies have looked at the barriers that the non-physician health professionals face. Ultimately, we found that one quarter of these health professionals found insurance coverage to be a current challenge to providing weight management care, and that over half of them felt improved coverage would help facilitate weight loss. These findings were consistent regardless of the income level of the patient populations.

13 Dec

Posted at 01:57h in Author Interviews, Lipids, Nutrition, Weight Research
MedicalResearch.com Interview with: Dr. Koji Ishiguro National Agriculture and Food Research Organization Japan MedicalResearch.com: What is the background for this study? Response: -Sweet potato (Ipomoea batatas L.) roots are not only used for human consumption, they are used to make starch materials, processed foods, and distilled spirits in Japan. Starch use accounts for about 15% (131,500 tons) of total sweet potato production. Starch residues are discharged during starch production and are mainly used in animal feed and compost. Large amounts of the wastewater, which can cause serious environmental problems, are discarded after clarification. Investigation into the uses of the by-products of the sweet potato starch industry would benefit both the environment and industry.